hsa‑miR‑455‑3P as a predictive biomarker of anemia in patients with non‑small cell lung cancer treated with carboplatin plus paclitaxel-Reference-Cited by-同舟云学术

hsa‑miR‑455‑3P as a predictive biomarker of anemia in patients with non‑small cell lung cancer treated with carboplatin plus paclitaxel

Published:2024-03-21 Issue:5 Volume:27 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Vasconcelos Pedro¹,Seguin Cecília¹,Barbeiro Aristóteles¹,Zambon Lair¹,Honma Helen¹,Perroud Jr Aurício¹,Geraldo Murilo²,Pincinato Eder¹,Moriel Patricia³

Affiliation:

1. School of Medical Science, Universidade Estadual de Campinas, Campinas, São Paulo 13083‑888, Brazil

2. Institute of Biology, Universidade Estadual de Campinas, Campinas, São Paulo 13083‑970, Brazil

3. Faculty of Pharmaceutical Science, Universidade Estadual de Campinas, Campinas, São Paulo 13083‑871, Brazil

Publisher

Spandidos Publications

Reference38 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Non-Small cell lung cancer: Epidemiology, screening, diagnosis, and treatment;Duma;Mayo Clin Proc,2019

3. Screening for lung cancer;Sateia;Semin.Oncol,2017

4. Targeted therapy and immunotherapy in the treatment of non-small cell lung cancer;Shroff;Radiol Clin North Am,2018

5. Targeting molecular alterations in non-small-cell lung cancer: What's next?;López-Castro;Per Med,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quercetin and its nanoformulations as promising agents for lung cancer treatment: A focus on molecular mechanisms;Journal of Drug Delivery Science and Technology;2024-09